Physician profile
Daniel Gregory Benson
NPI 1629369772
$627.27
in general payments reported to CMS, 2019-2025
15 companies · $26.67 in 2025
The $26.67 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $465 · 2020: $36.56 · 2022: $98.55 · 2025: $26.67.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $26.67.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $26.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $140.39 | 2019 | |
| Astellas Pharma US INC | $111.42 | 2019 | |
| Depuy Synthes Sales INC. | $78.66 | 2022 | |
| Travere Therapeutics, INC. | $45.70 | 2019 | |
| Bk Medical Holding Company INC. | $36.56 | 2020 | |
| Healthtronics Stone Solutions, LLC | $33.08 | 2019 | |
| Janssen Biotech, INC. | $31.33 | 2019-2022 | |
| Ethicon US, LLC | $26.67 | 2025 | Echelon; Endopath |
| Ferring Pharmaceuticals INC. | $24.98 | 2019 | |
| Amgen INC. | $21.87 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $18.65 | 2019 | |
| Dendreon Pharmaceuticals LLC | $16.32 | 2019 | |
| Neotract INC. | $15.43 | 2019 | |
| Pfizer INC. | $13.99 | 2019 | |
| Cook Medical LLC | $12.22 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Benson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.